AEKYUNG CHEMICAL CO., LTD

As of June 30, 2026, AEKYUNG CHEMICAL CO., LTD carries a market capitalization of 502.60B, placing it among publicly traded companies globally. Its enterprise value stands at 1.02T, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, AEKYUNG CHEMICAL CO., LTD has 48.28M shares outstanding.

As of June 30, 2026, AEKYUNG CHEMICAL CO., LTD trades at a trailing price-to-earnings ratio of 25.19. The price-to-sales ratio is 0.32, and the price-to-book ratio stands at 0.69.

As of June 30, 2026, AEKYUNG CHEMICAL CO., LTD trades at an EV/EBITDA multiple of 12.00 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.64 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 28.35 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 1.02T versus a market cap of 502.60B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, AEKYUNG CHEMICAL CO., LTD maintains a current ratio of 1.16, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 80.14, indicating elevated leverage, while an interest coverage ratio of 4.15 demonstrates adequate ability to service its debt obligations.

Over the twelve months ended June 30, 2026, AEKYUNG CHEMICAL CO., LTD posted a return on equity (ROE) of 2.78, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 2.02 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 1.34, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 2.87, useful for judging operating efficiency across full business cycles. The company generates approximately 2.19B in revenue per employee across its workforce of 722.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 5.22 indicates how many times AEKYUNG CHEMICAL CO., LTD sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, AEKYUNG CHEMICAL CO., LTD recorded 7.29B in income tax expense. That works out to an effective tax rate of 28.60, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 25.50B, leaving 19.96B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 23, 2026, AEKYUNG CHEMICAL CO., LTD's stock has declined approximately 1.70% over the past 52 weeks. The 50-day moving average sits at 10,461.60, while the 200-day moving average is 10,884.40.

Over the twelve months ended June 30, 2026, AEKYUNG CHEMICAL CO., LTD generated 1.58T in revenue and converted that into 19.96B in net income, yielding earnings per share of 377.03. EBITDA reached 84.61B, while operating income came in at 35.81B.

As of June 30, 2026, AEKYUNG CHEMICAL CO., LTD holds 76.18B in cash and equivalents against 586.89B in total debt, resulting in a net debt position of 517.20B. Total book value stands at 730.39B, with working capital of 96.03B providing operational flexibility.

AEKYUNG CHEMICAL CO., LTD produced 26.26B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -116.73B in capital expenditures, free cash flow totaled -90.47B - equivalent to -1,873.34 per share.

Over the twelve months ended June 30, 2026, AEKYUNG CHEMICAL CO., LTD posted a gross margin of 10.47, reflecting its pricing power and cost economics. The operating margin of 2.27 and net profit margin of 1.26 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, AEKYUNG CHEMICAL CO., LTD paid dividends of 139.97 per share. The dividend payout ratio of 41.07 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield is negative at -17.99: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -13.36, meaning AEKYUNG CHEMICAL CO., LTD raised more capital through share issuance and new debt than it returned via dividends and buybacks.

AEKYUNG CHEMICAL CO., LTD's most recent stock split took place on September 6, 2016 with a 1:10 split ratio.

As of June 30, 2026, AEKYUNG CHEMICAL CO., LTD has an Altman Z-Score of 1.90, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.